December 2007
Main Article
For 2007, Washington G-2 Reports values molecular diagnostic testing at $4.1 billion and estimates growth of approximately 19% each year through 2010. Last year, estimates for the U.S. market for molecular diagnostic testing totaled $3.5 billion, with infectious disease testing accounting for about half of that amount and the remainder comprising blood screening and genetic testing.
Subscribers: click here for the full story
Non-Subscribers: click here to subscribe
|
|
|
 Archives
|
|
December 2007 - Table of Contents
